Newly identified form of phenotypic plasticity of cancer: immunogenic mimicry
Authors:
Open Access
- 8 February 2023
- journal article
- review article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 42 (1) , 323-334
Abstract
Cancer plasticity is now a recognized new hallmark of cancer which is due to disturbances of cell differentiation programs. It is manifested not only in various forms like the best-known epithelial-mesenchymal transition (EMT) but also in vasculogenic and megakaryocytic mimicries regulated by EMT-specific or less-specific transcription factors such as HIF1a or STAT1/2. Studies in the past decades provided ample data that cancer plasticity can be manifested also in the expression of a vast array of immune cell genes; best-known examples are PDL1/CD274, CD47, or IDO, and we termed it immunogenic mimicry (IGM). However, unlike other types of plasticities which are epigenetically regulated, expression of IGM genes are frequently due to gene amplifications. It is important that the majority of the IGM genes are regulated by interferons (IFNs) suggesting that their protein expressions are regulated by the immune microenvironment. Most of the IGM genes have been shown to be involved in immune escape of cancers broadening the repertoire of these mechanisms and offering novel targets for immunotherapeutics.Keywords
Funding Information
- NKFIH (K-135540)
- Community Found Michigan (000)
- Merit Medical Systems (000)
This publication has 112 references indexed in Scilit:
- INTERFEROME v2.0: an updated database of annotated interferon-regulated genesNucleic Acids Research, 2012
- Hypoxia Negatively Regulates Antimetastatic PEDF in Melanoma Cells by a Hypoxia Inducible Factor-Independent, Autophagy Dependent MechanismPLOS ONE, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- A Role for ATF2 in Regulating MITF and Melanoma DevelopmentPLOS Genetics, 2010
- Regulation of the Embryonic Morphogen Nodal by Notch4 Facilitates Manifestation of the Aggressive Melanoma PhenotypeCancer Research, 2010
- Development and Cancer: At the Crossroads of Nodal and Notch SignalingCancer Research, 2009
- Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cellsProceedings of the National Academy of Sciences, 2008
- The physiology and pathology of the EMTEMBO Reports, 2008
- The magic of the hypoxia-signaling cascadeCellular and Molecular Life Sciences, 2008
- The Hallmarks of CancerCell, 2000